Format

Send to

Choose Destination
Cancer Discov. 2017 Oct;7(10):OF1. doi: 10.1158/2159-8290.CD-NB2017-126. Epub 2017 Sep 8.

First-Ever CAR T-cell Therapy Approved in U.S.

[No authors listed]

Abstract

The first chimeric antigen receptor T-cell therapy, tisagenlecleucel, received FDA approval for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia who haven't responded to standard therapy or who have relapsed at least twice.

PMID:
28887358
DOI:
10.1158/2159-8290.CD-NB2017-126
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center